ATP5G1 Antibody (1A12): sc-293324

ATP5G1 Antibody (1A12) is a mouse monoclonal IgG1 kappa light chain antibody that detects ATP5G1 protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-ATP5G1 antibody (1A12) is available as the non-conjugated format. ATP5G1, also known as ATP synthase subunit gamma, plays a crucial role in mitochondrial function by facilitating the synthesis of adenosine triphosphate (ATP), the primary energy currency of the cell. ATP5G1 is located in the inner mitochondrial membrane, where ATP5G1 forms part of the ATP synthase complex, which is essential for oxidative phosphorylation—a process that generates ATP through the electron transport chain. Proper functioning of ATP5G1 is vital for cellular energy production, and any dysfunction can lead to a range of metabolic disorders and contribute to the pathogenesis of various diseases, including neurodegenerative conditions and cancer. Chromosome 17, where ATP5G1 gene is located, is also significant due to its association with key tumor suppressor genes such as p53 and BRCA1, which are critical for maintaining genomic stability and preventing tumorigenesis. ATP5G1 monoclonal antibody (1A12) is an invaluable tool for researchers studying mitochondrial function, energy metabolism, and the molecular mechanisms underlying various diseases.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

ATP5G1 Antibody (1A12) References:

1. Birt-Hogg-Dubé Syndrome.  |  Welsch, MJ., et al. 2005. Int J Dermatol. 44: 668-73. PMID: 16101870
2. BLIMP1 regulates cell growth through repression of p53 transcription.  |  Yan, J., et al. 2007. Proc Natl Acad Sci U S A. 104: 1841-6. PMID: 17264218
3. Neurofibromatosis 1, and Not TP53, seems to be the main target of chromosome 17 deletions in de novo acute myeloid leukemia.  |  Suela, J., et al. 2007. J Clin Oncol. 25: 1151-2; author reply 1152-3. PMID: 17369586
4. Quantification of N-acetylaspartic acid in urine by LC-MS/MS for the diagnosis of Canavan disease.  |  Al-Dirbashi, OY., et al. 2007. J Inherit Metab Dis. 30: 612. PMID: 17632691
5. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.  |  Farrell, CJ. and Plotkin, SR. 2007. Neurol Clin. 25: 925-46, viii. PMID: 17964021
6. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.  |  Tai, YC., et al. 2007. J Natl Cancer Inst. 99: 1811-4. PMID: 18042939
7. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.  |  Murakami, N., et al. 2008. Pediatr Neurol. 38: 50-2. PMID: 18054694
8. Strategies for ovarian cancer prevention.  |  Dann, RB., et al. 2007. Obstet Gynecol Clin North Am. 34: 667-86, viii. PMID: 18061863
9. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes.  |  Nusbaum, R., et al. Breast Dis. 27: 21-50. PMID: 17917139